← Leaderboards
Nathaniel Aaron Jeske
University Of Texas Hlth Sci Ctr San Ant
$4,890,309
Attributed
$6,096,536
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $645.3K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,096,536 · 7
By mechanism
R01$5,172,254 · 4
R21$844,375 · 2
F32$79,907 · 1
Top collaborators
- Yu Shin Kim4 shared
- Glenn M Toney4 shared
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Steven W. Mifflin$8,624,647
- Glenn M Toney$12,386,836
- Wouter Koek$4,458,124
- Gregory R Mundy$7,763,862
- Sondra Perdue$1,207,579
Others in their field
Top investigators on “Quality Of Life”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Gregory H Reaman · National Childhood Cancer Foundation$264,644,476
- David R. Weir · University Of Michigan At Ann Arbor$263,050,576
- Richard K. Wilson · Washington University$198,912,538
Research focus
Quality Of LifeBiochemicalAffectPeripheralNeuronsAfferent NeuronsPainNociceptorsMolecularPersistent PainProteinsAnalgesicsPathway InteractionsReceptor ActivationStimulusReceptorRegulationMediatingMissionAmericanA Kinase Anchoring ProteinPhosphorylationScaffolding ProteinChronic Pain
Grant awards (21)
Chronic Intermittent Hypoxia and Hyperalgesic Priming$560,256
R01 · FY2025 · NS · contact PI
Chronic Intermittent Hypoxia and Hyperalgesic Priming$603,829
R01 · FY2024 · NS · contact PI
Chronic Intermittent Hypoxia and Hyperalgesic Priming$629,255
R01 · FY2023 · NS · contact PI
Chronic Intermittent Hypoxia and Hyperalgesic Priming - Administrative Supplement$16,001
R01 · FY2023 · NS · contact PI
Autophagy and Neuropathic Pain$425,000
R21 · FY2020 · NS · contact PI
Scaffolding the Transition to Chronic Pain$309,682
R01 · FY2017 · NS · contact PI
Scaffolding Opiate Analgesia$190,625
R21 · FY2017 · DA · contact PI
Scaffolding the Transition to Chronic Pain$314,147
R01 · FY2016 · NS · contact PI
Scaffolding Opiate Analgesia$228,750
R21 · FY2016 · DA · contact PI
Scaffolding the Transition to Chronic Pain$318,529
R01 · FY2015 · NS · contact PI
Scaffolding the Transition to Chronic Pain$319,594
R01 · FY2014 · NS · contact PI
Scaffolding the Transition to Chronic Pain$384,448
R01 · FY2013 · NS · contact PI
Scaffolding the Transition to Chronic Pain$21,735
R01 · FY2013 · NS · contact PI
AKAP MODULATES TRPV1 PHOSPHORYLATION AND SENSITIZATION$318,347
R01 · FY2011 · NS · contact PI
AKAP MODULATES TRPV1 PHOSPHORYLATION AND SENSITIZATION$321,596
R01 · FY2010 · NS · contact PI
AKAP MODULATES TRPV1 PHOSPHORYLATION AND SENSITIZATION$50,000
R01 · FY2010 · NS · contact PI
AKAP MODULATES TRPV1 PHOSPHORYLATION AND SENSITIZATION$324,662
R01 · FY2009 · NS · contact PI
AKAP MODULATES TRPV1 PHOSPHORYLATION AND SENSITIZATION$323,750
R01 · FY2008 · NS · contact PI
Integrins and mechanoreception in the inflames TMJ.$356,423
R01 · FY2006 · DE · contact PI
Cannabinoid-Induced Desensitization of TRPV1 Receptors$35,131
F32 · FY2006 · DE · contact PI
Cannabinoid-Induced Desensitization of TRPV1 Receptors$44,776
F32 · FY2005 · DE